Farrar Jason E, Nater Michelle, Caywood Emi, McDevitt Michael A, Kowalski Jeanne, Takemoto Clifford M, Talbot C Conover, Meltzer Paul, Esposito Diane, Beggs Alan H, Schneider Hal E, Grabowska Agnieszka, Ball Sarah E, Niewiadomska Edyta, Sieff Colin A, Vlachos Adrianna, Atsidaftos Eva, Ellis Steven R, Lipton Jeffrey M, Gazda Hanna T, Arceci Robert J
Division of Pediatric Oncology, Department of Oncology, Kimmel Comprehensive Cancer Center.
Blood. 2008 Sep 1;112(5):1582-92. doi: 10.1182/blood-2008-02-140012. Epub 2008 Jun 5.
Diamond-Blackfan anemia (DBA) is an inherited bone marrow failure syndrome characterized by anemia, congenital abnormalities, and cancer predisposition. Small ribosomal subunit genes RPS19, RPS24, and RPS17 are mutated in approximately one-third of patients. We used a candidate gene strategy combining high-resolution genomic mapping and gene expression microarray in the analysis of 2 DBA patients with chromosome 3q deletions to identify RPL35A as a potential DBA gene. Sequence analysis of a cohort of DBA probands confirmed involvement RPL35A in DBA. shRNA inhibition shows that Rpl35a is essential for maturation of 28S and 5.8S rRNAs, 60S subunit biogenesis, normal proliferation, and cell survival. Analysis of pre-rRNA processing in primary DBA lymphoblastoid cell lines demonstrated similar alterations of large ribosomal subunit rRNA in both RPL35A-mutated and some RPL35A wild-type patients, suggesting additional large ribosomal subunit gene defects are likely present in some cases of DBA. These data demonstrate that alterations of large ribosomal subunit proteins cause DBA and support the hypothesis that DBA is primarily the result of altered ribosomal function. The results also establish that haploinsufficiency of large ribosomal subunit proteins contributes to bone marrow failure and potentially cancer predisposition.
先天性纯红细胞再生障碍性贫血(DBA)是一种遗传性骨髓衰竭综合征,其特征为贫血、先天性异常和癌症易感性。小核糖体亚基基因RPS19、RPS24和RPS17在大约三分之一的患者中发生突变。我们采用了一种候选基因策略,将高分辨率基因组定位和基因表达微阵列相结合,对2例3号染色体长臂缺失的DBA患者进行分析,以确定RPL35A为潜在的DBA基因。对一组DBA先证者的序列分析证实RPL35A与DBA有关。短发夹RNA抑制实验表明,Rpl35a对28S和5.8S rRNA的成熟、60S亚基的生物合成、正常增殖和细胞存活至关重要。对原发性DBA淋巴母细胞系前体rRNA加工的分析表明,在RPL35A突变的患者和一些RPL35A野生型患者中,大核糖体亚基rRNA都有类似的改变,这表明在某些DBA病例中可能还存在其他大核糖体亚基基因缺陷。这些数据表明,大核糖体亚基蛋白的改变会导致DBA,并支持DBA主要是核糖体功能改变所致的假说。研究结果还证实,大核糖体亚基蛋白的单倍剂量不足会导致骨髓衰竭,并可能引发癌症易感性。